Brief Information of the Cell Line and Protein
Cell Line ID: CL000504 , EBC-1
Synonyms
EBC-1/original
EBC1
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_2891
Protein ID: PT01042 , Serine/threonine-protein kinase PAK 1
Gene Name PAK1
Organism Homo sapiens, Human
Protein Classification Kinase
Uniprot ID Q13153
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000504  Protein ID: PT01042
 
Compound ID Compound Name Compound Formula
CP0256326
CHEMBL3770588
   Show/Hide
C28H31ClN6O
 1
1
IC50 = 45 nM
   TI
   LI
   LO
   TS
CP0156094
6-[2-chloro-4-(6-methylpyridin-2-yl)phenyl]-8-[[(4S)-3,3-difluoropiperidin-4-yl]methyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C26H25ClF2N6O
 1
1
IC50 = 53 nM
   TI
   LI
   LO
   TS
CP0486462
CHEMBL3769478
   Show/Hide
C26H27ClN6O3
 1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0070883
8-[(5-amino-1,3-dioxan-2-yl)methyl]-6-[2-chloro-4-(6-methylpyridin-2-yl)phenyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C25H25ClN6O3
 1
1
IC50 = 69 nM
   TI
   LI
   LO
   TS
CP0090236
6-[2-chloro-4-(6-methylpyridin-2-yl)phenyl]-8-(5,9-dioxa-2-azaspiro[3.5]nonan-7-ylmethyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C27H27ClN6O3
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0072137
2-N-[(4-chloro-1H-benzimidazol-5-yl)methyl]-4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-N-ethylpyrimidine-2,4-diamine
   Show/Hide
C20H21ClN8
 1
1
IC50 = 85 nM
   TI
   LI
   LO
   TS
CP0677749
N2-((4-Chloro-1H-benzo[d]imidazol-5-yl)methyl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-N2-methylpyrimidine-2,4-diamine
   Show/Hide
C19H19ClN8
 1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0698981
(S)-N2-(1-(1H-Indol-5-yl)ethyl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
   Show/Hide
C20H21N7
 1
1
IC50 = 120 nM
   TI
   LI
   LO
   TS
CP0231643
8-[(4-aminocyclohexyl)methyl]-6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C27H30ClN7O
 1
1
IC50 = 124 nM
   TI
   LI
   LO
   TS
CP0231644
6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)-8-(piperidin-4-ylmethyl)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C26H28ClN7O
 1
1
IC50 = 145 nM
   TI
   LI
   LO
   TS
CP0256327
8-(4-aminobutyl)-6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C24H26ClN7O
 1
1
IC50 = 147 nM
   TI
   LI
   LO
   TS
CP0452337
8-[(5-amino-1,3-dioxan-2-yl)methyl]-6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C25H26ClN7O3
 1
1
IC50 = 148 nM
   TI
   LI
   LO
   TS
CP0098902
6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-8-ethyl-2-[2-(1-methylpiperidin-4-yl)ethylamino]pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C28H32ClN7O
 1
1
IC50 = 222 nM
   TI
   LI
   LO
   TS
CP0709895
N2-[(1S)-1-(1H-Benzimidazol-5-yl)ethyl]-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
   Show/Hide
C19H20N8
 1
1
IC50 = 281 nM
   TI
   LI
   LO
   TS
CP0256325
8-[(4-aminocyclohexyl)methyl]-6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C26H28ClN7O
 1
1
IC50 = 341 nM
   TI
   LI
   LO
   TS
CP0252383
2-N-[(4-chloro-1H-benzimidazol-5-yl)methyl]-4-N-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
   Show/Hide
C18H17ClN8
 1
1
IC50 = 362 nM
   TI
   LI
   LO
   TS
CP0111952
6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(methylamino)-8-[[(2R)-morpholin-2-yl]methyl]pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C24H24ClN7O2
 1
1
IC50 = 399 nM
   TI
   LI
   LO
   TS
CP0472537
6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)-8-[(2-oxopiperidin-4-yl)methyl]pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C26H26ClN7O2
 1
1
IC50 = 813 nM
   TI
   LI
   LO
   TS
CP0256324
6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-2-(ethylamino)-8-(3-hydroxypropyl)pyrido[2,3-d]pyrimidin-7-one
   Show/Hide
C23H23ClN6O2
 1
1
IC50 = 980 nM
   TI
   LI
   LO
   TS
CP0733200
N2-((trans-4-Aminocyclohexyl)methyl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
   Show/Hide
C17H25N7
 1
1
IC50 = 2200 nM
   TI
   LI
   LO
   TS